Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Food allergy startup bags $17M for oral immunotherapy
Fierce Biotech
Friday, November 22, 2013 - 11:04am
tags:
food allergies, Allergen Research Corp
J&J Said to Narrow Bidder List to 3 for Diagnostics Business
Bloomberg
Friday, November 22, 2013 - 11:01am
tags:
JNJ, M&A, diagnostics, Ortho Clinical Diagnostics
Novartis Sets $5 Billion Buyback, Adds Business Segments
Bloomberg
Friday, November 22, 2013 - 10:59am
tags:
Novartis, share repurchase, dermatology, heart failure, respiratory health, cell therapy
A Closer Look At Neuralstem's ALS Treatment
Forbes
Friday, November 22, 2013 - 10:33am
tags:
Neuralstem, ALS, amyotrophic lateral sclerosis
Cyberonics soars on a strong Q2 results, record sales, boosted guidance
Mass Device
Friday, November 22, 2013 - 10:30am
tags:
earnings, devices, Cyberonics
Sam Waksal, A Hepatitis C Medicine And An FDA Warning Letter
Pharmalot
Friday, November 22, 2013 - 10:28am
tags:
hepatitis C, FDA, Ribasphere, Kadmon
Novartis chases Pfizer in hot new breast cancer drug area
Yahoo/Reuters
Friday, November 22, 2013 - 10:27am
tags:
Pfizer, breast cancer, Novartis
Amarin faces another setback on expanded use of its lead drug
Yahoo/Reuters
Friday, November 22, 2013 - 10:24am
tags:
Amarin, Vascepa
Glaxo, Pfizer's HIV Treatment Recommended by EU Regulator
Bloomberg
Friday, November 22, 2013 - 10:22am
tags:
GSK, Pfizer, HIV, Europe, Tivicay
Keep an Eye on Pacific Biosciences, Epizyme, and Merrimack Today
Motley Fool
Friday, November 22, 2013 - 10:21am
tags:
Pacific Biosciences, Epizyme, Merrimack Pharmaceuticals
Positive Trial Data Sends Galena Biopharma Shares Higher
Wall St Cheat Sheet
Friday, November 22, 2013 - 10:20am
tags:
Galena Biopharma, FLP, Folate Binding Protein
Biogen wins protection for MS drug Tecfidera in Europe
Yahoo/Reuters
Friday, November 22, 2013 - 9:01am
tags:
Biogen Idec, MS, multiple sclerosis, Europe, Tecfidera
The Good News, Bad News for Belviq: Bad News First…
Motley Fool
Friday, November 22, 2013 - 8:35am
tags:
Belviq, Eisai, Arena Pharmaceuticals
Bayer receives new approval for Eylea eye treatment in Japan
Yahoo/Reuters
Friday, November 22, 2013 - 8:29am
tags:
Bayer, Japan, Eylea, macular edema
Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Bloomberg
Friday, November 22, 2013 - 8:15am
tags:
Sanofi, Regeneron, rheumatoid arthritis, Sarilumab
New Research And Competition Could Hurt AbbVie's Other Blockbuster
Seeking Alpha
Thursday, November 21, 2013 - 2:05pm
tags:
AbbVie, Auxilium, GSK, Eli Lilly, Androgel
Actavis cutting 30% of U.S. sales organization
Fierce Pharma
Thursday, November 21, 2013 - 1:45pm
tags:
Actavis, layoffs, M&A, Warner Chilcott
The Race For A Cure For Cancer
Seeking Alpha
Thursday, November 21, 2013 - 12:09pm
tags:
cancer, Merck, Bristol-Myers Squibb, Roche, Peregrine Pharmaceuticals
Amicus' 'Transformative' Changes Look More Like Big Step Backward
TheStreet.com
Thursday, November 21, 2013 - 12:07pm
tags:
Amicus Therapeutics, GSK, Sanofi, Biomarin, Callidus Biopharma, Amigal
Next Bard vaginal mesh trial set for December; settlement rumors remain
Fierce Medical Devices
Thursday, November 21, 2013 - 12:06pm
tags:
CR Bard, vaginal mesh, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.